XML 26 R4.htm IDEA: XBRL DOCUMENT v2.4.0.6
Condensed Consolidated Statements of Operations and Comprehensive Loss (USD $)
In Thousands, except Per Share data, unless otherwise specified
3 Months Ended 36 Months Ended
Mar. 31, 2013
Mar. 31, 2012
Mar. 31, 2013
Expenses:      
Research and development $ 16,503 $ 8,150 $ 75,517
General and administrative 2,400 1,199 13,941
Acquired in-process research and development     15,130
Total expenses 18,903 9,349 104,588
Loss from operations (18,903) (9,349) (104,588)
Interest income 34 20 244
Other expense     (1,661)
Net loss (18,869) (9,329) (106,005)
Net loss per share applicable to common stockholders - basic and diluted (in dollars per share) $ (0.66) $ (13.59) $ (14.80)
Weighted-average number of common shares used in net loss per share applicable to common stockholders - basic and diluted (in shares) 28,798 687 7,163
Comprehensive Loss $ (18,869) $ (9,329) $ (106,005)